As soon as you hear the name cholesterol, you might remember the factors that increase heart problems, but do you know that ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...

A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.